CompanyKite Pharma EU B.V.
ATC codeL01X
EU authorised2020-12-14
· 5 yr ago
Flags
Orphan
Conditional approval
EMA EPAR
Evidence dossier ↗
Tecartus CONFIRMED
brexucabtagene autoleucel · MCL
Current stage: 6 · first detected 2026-06-25
Also known as: tecartus
Nordic decisions
| Country | Body | Verdict | Date | Source |
|---|---|---|---|---|
| Danmark | Medicinrådet | Ikke anbefalet | 2026-01-21 | link |
| Sverige | NT-rådet | kan användas | 2022-11-24 | link |
| Norge | Beslutningsforum | Innføres | 2024-09-23 | link |
Status timeline
| Date | Body | Status | Stage | Source |
|---|---|---|---|---|
| No status history. | ||||